BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 29525278)

  • 41. Passive transfer and rate of decay of maternal antibody against African horse sickness virus in South African Thoroughbred foals.
    Crafford JE; Lourens CW; Gardner IA; Maclachlan NJ; Guthrie AJ
    Equine Vet J; 2013 Sep; 45(5):604-7. PubMed ID: 23294121
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-structural protein NS3/NS3a is required for propagation of bluetongue virus in Culicoides sonorensis.
    Feenstra F; Drolet BS; Boonstra J; van Rijn PA
    Parasit Vectors; 2015 Sep; 8():476. PubMed ID: 26383094
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular epidemiology of African horse sickness virus based on analyses and comparisons of genome segments 7 and 10.
    Zientara S; Sailleau C; Plateau E; Moulay S; Mertens PP; Crucière C
    Arch Virol Suppl; 1998; 14():221-34. PubMed ID: 9785509
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A field investigation of an African horse sickness outbreak in the controlled area of South Africa in 2016.
    Grewar JD; Weyer CT; Venter GJ; van Helden LS; Burger P; Guthrie AJ; Coetzee P; Labuschagne K; Bührmann G; Parker BJ; Thompson PN
    Transbound Emerg Dis; 2019 Mar; 66(2):743-751. PubMed ID: 30449073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus.
    Kanai Y; van Rijn PA; Maris-Veldhuis M; Kaname Y; Athmaram TN; Roy P
    Vaccine; 2014 Sep; 32(39):4932-7. PubMed ID: 25045805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Real time RT-PCR assays for detection and typing of African horse sickness virus.
    Bachanek-Bankowska K; Maan S; Castillo-Olivares J; Manning NM; Maan NS; Potgieter AC; Di Nardo A; Sutton G; Batten C; Mertens PP
    PLoS One; 2014; 9(4):e93758. PubMed ID: 24721971
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48h before, or 48h after challenge.
    Calvo-Pinilla E; de la Poza F; Gubbins S; Mertens PP; Ortego J; Castillo-Olivares J
    Antiviral Res; 2015 Apr; 116():27-33. PubMed ID: 25643968
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative Genome Analysis of All Nine African Horse Sickness Serotypes Isolated From Equine Fatalities in Kenya and South Africa.
    Hoffmann B; Joseph S; Patteril NAG; Caveney MR; Elizabeth SK; Muhammed R; Wernery R; Wernery U
    J Equine Vet Sci; 2022 Dec; 119():104137. PubMed ID: 36223818
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Humoral antibody response of 10 horses after vaccination against African horse sickness with an inactivated vaccine containing all 9 serotypes in one injection.
    Wernery U; Rodriguez M; Raghavan R; Syriac G; Miriam Thomas M S; Elizabeth SK; Federico Ronchi G; Muhammed R; Patteril NA; Joseph S
    Equine Vet J; 2021 Jul; 53(4):826-833. PubMed ID: 33011979
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of two trapping methods for Culicoides biting midges and determination of African horse sickness virus prevalence in midge populations at Onderstepoort, South Africa.
    Scheffer EG; Venter GJ; Labuschagne K; Page PC; Mullens BA; MacLachlan NJ; Osterrieder N; Guthrie AJ
    Vet Parasitol; 2012 Apr; 185(2-4):265-73. PubMed ID: 22014560
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Control and eradication of African horse sickness with vaccine.
    Sánchez-Vizcaíno JM
    Dev Biol (Basel); 2004; 119():255-8. PubMed ID: 15742636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vaccination of mice with a modified Vaccinia Ankara (MVA) virus expressing the African horse sickness virus (AHSV) capsid protein VP2 induces virus neutralising antibodies that confer protection against AHSV upon passive immunisation.
    Calvo-Pinilla E; de la Poza F; Gubbins S; Mertens PP; Ortego J; Castillo-Olivares J
    Virus Res; 2014 Feb; 180():23-30. PubMed ID: 24333835
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Further studies on the efficacy of an inactivated African horse sickness serotype 4 vaccine.
    House JA; Lombard M; Dubourget P; House C; Mebus CA
    Vaccine; 1994 Feb; 12(2):142-4. PubMed ID: 8147096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An African horse sickness virus serotype 4 recombinant canarypox virus vaccine elicits specific cell-mediated immune responses in horses.
    El Garch H; Crafford JE; Amouyal P; Durand PY; Edlund Toulemonde C; Lemaitre L; Cozette V; Guthrie A; Minke JM
    Vet Immunol Immunopathol; 2012 Sep; 149(1-2):76-85. PubMed ID: 22763149
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of nonstructural protein NS3 of African horsesickness virus (AHSV): evidence for a cytotoxic effect of NS3 in insect cells, and characterization of the gene products in AHSV infected Vero cells.
    van Staden V; Stoltz MA; Huismans H
    Arch Virol; 1995; 140(2):289-306. PubMed ID: 7710356
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Full protection against African horsesickness (AHS) in horses induced by baculovirus-derived AHS virus serotype 4 VP2, VP5 and VP7.
    Martínez-Torrecuadrada JL; Díaz-Laviada M; Roy P; Sánchez C; Vela C; Sánchez-Vizcaíno JM; Casal JI
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1211-21. PubMed ID: 8683209
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunization with VP2 is sufficient for protection against lethal challenge with African horsesickness virus Type 4.
    Stone-Marschat MA; Moss SR; Burrage TG; Barber ML; Roy P; Laegreid WW
    Virology; 1996 Jun; 220(1):219-22. PubMed ID: 8659117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inactivated and adjuvanted vaccine for the control of the African horse sickness virus serotype 9 infection: evaluation of efficacy in horses and guinea-pig model.
    Lelli R; Molini U; Ronchi GF; Rossi E; Franchi P; Ulisse S; Armillotta G; Capista S; Khaiseb S; Di Ventura M; Pini A
    Vet Ital; 2013; 49(1):89-98. PubMed ID: 23564590
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of antibody responses to African horse sickness virus (AHSV) in ponies after vaccination with recombinant modified vaccinia Ankara (MVA).
    Chiam R; Sharp E; Maan S; Rao S; Mertens P; Blacklaws B; Davis-Poynter N; Wood J; Castillo-Olivares J
    PLoS One; 2009 Jun; 4(6):e5997. PubMed ID: 19543394
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recommendations for African horse sickness vaccines for use in nonendemic areas.
    House JA
    Rev Elev Med Vet Pays Trop; 1993; 46(1-2):77-81. PubMed ID: 8134660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.